Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 6013  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,139 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Methods and Material
 » Results
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed898    
    Printed40    
    Emailed0    
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2021  |  Volume : 69  |  Issue : 2  |  Page : 354-359

Nonconvulsive Status Epilepticus in Metabolic Encephalopathy in Indonesia Referral Hospital


1 Department of Neurology, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
2 Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo General Hospital, Jakarta, Indonesia

Date of Submission21-Oct-2020
Date of Decision22-Oct-2020
Date of Acceptance20-Jan-2021
Date of Web Publication24-Apr-2021

Correspondence Address:
Fitri Octaviana
Department of Neurology, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo General Hospital, Jakarta
Indonesia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.314533

Rights and Permissions

 » Abstract 


Background: Nonconvulsive status epilepticus (NCSE) is often underdiagnosed in patients with metabolic encephalopathy (ME). The diagnosis of ME should be made specifically to recognize the underlying etiology. Delay in seizure identification and making a diagnosis of NCSE contributed to the poor outcome.
Objective: This study aimed to find the incidence and outcome of NCSE in patients with ME.
Methods and Material: This was an observational prospective cross-sectional study in patients with ME in emergency and critical care units in Cipto Mangunkusumo General Hospital. The diagnosis of NCSE was based on EEG using Salzburg Criteria for Nonconvulsive Status Epilepticus (SCNC). The outcome was assessed within 30 days after the NCSE diagnosis has been made.
Results: A total of 50 patients with ME were involved in this study. NCSE was confirmed in 32 subjects (64%). The most common etiology of ME was sepsis (58%). The mortality rate in the NCSE and non-NCSE group was 40.6% vs 44.4%. Multiple aetiologies were risk factors to poor outcome in the NCSE group.
Conclusions: The incidence of NCSE among patients with ME at our hospital was high. Despite the anti-epileptic treatment of the NCSE group, the underlying cause of ME is still the main factor that affected the outcome. Therefore, aggressive treatment of anti-epileptic drug (AED) should be very carefully considered knowing the possible side-effect that might worsen the outcome of patients with ME.


Keywords: Metabolic encephalopathy, mortality, non-convulsive status epilepticus
Key Messages: Treating the underlying etiology of nonconvulsive status epilepticus was important to decrease the mortality rate; aggressive anti-epileptic treatment should be carefully considered since AED may contribute to morbidity and mortality of critically ill patients.


How to cite this article:
Octaviana F, Bestari AP, Loho AM, Indrawati LA, Wiratman W, Kurniawan M, Sugiarto A, Budikayanti A. Nonconvulsive Status Epilepticus in Metabolic Encephalopathy in Indonesia Referral Hospital. Neurol India 2021;69:354-9

How to cite this URL:
Octaviana F, Bestari AP, Loho AM, Indrawati LA, Wiratman W, Kurniawan M, Sugiarto A, Budikayanti A. Nonconvulsive Status Epilepticus in Metabolic Encephalopathy in Indonesia Referral Hospital. Neurol India [serial online] 2021 [cited 2021 Jun 23];69:354-9. Available from: https://www.neurologyindia.com/text.asp?2021/69/2/354/314533




Nonconvulsive status epilepticus (NCSE) is an epileptic seizure without prominent motoric features.[1] Electroencephalography (EEG) plays a vital role in the diagnosis of NCSE. The EEG activity of NCSE varied widely and some diagnostic criteria had been proposed.[2],[3] The Salzburg EEG criteria for NCSE was known to have high accuracy.[4],[5]

The mortality of NCSE patients was 7.7% to 57% and affected by the underlying etiology.[6],[7],[8] NCSE was found in the critically ill populations with various aetiologies, including metabolic encephalopathy (ME). Delay in diagnosis of NCSE might contribute to poor outcome.[9],[10] Patients with sepsis had a higher rate of non-convulsive seizures and poorer outcomes.[11] Seizure and NCSE could be the initial symptoms of ME.[12],[13] Clinical evidence of NCSE includes agitation, delirium, altered mental status without obvious convulsive seizure.[14] This study aimed to investigate the incidence and outcome of NCSE in ME at our hospital as a referral hospital in Indonesia.


 » Methods and Material Top


This was a cross-sectional prospective study in Cipto Mangunkusumo General Hospital Jakarta from July 2016 to July 2017. We recruited ≥18 years old ME patients without a history of epilepsy or previous antiepileptic drug usage. Patients with focal neurological deficits were excluded. ME was defined as decreased consciousness associated with metabolic abnormalities such as decreased liver function (increasing liver enzymes more than five times normal range), renal function (serum creatinine level >10 mg/dL or blood urea nitrogen level >100 mg/dL), hypoxic-ischemic condition (e.g. acute global cerebral hypoperfusion; patient who had cardiac resuscitation and return of spontaneous circulation), electrolyte imbalance (e.g., serum Na level <115 mg/dL, serum Ca level < 5 mg/dL, serum mg level <0.8 mg/dL) blood glucose abnormality (serum glucose level <36 mg/dL or >450 mg/dL), and septicaemia (supported with hyper/hypothermia, biochemistry parameters e.g., leucocytosis [white blood cell count >12,000/μL] or leukopenia [white blood cell count <4,000/μL]).[15],[16],[17] Informed consent was obtained from the patient's family.

EEG recording was performed to all patients that had been recruited in the emergency room, intensive care unit, and inpatient ward using Caldwell® ambulatory EEG machine with Arc® software. EEG was carried out for approximately 45–60 min to obtain at least 30 min of artifacts-free recording using the 10–20 International System. During the test, the level of consciousness was assessed by asking patients to do five things, which were: (1) “Say your name,” (2) “Repeat 1, 2, 3, ” (3) “Raise your arms,” (4) “Open your eyes,” and (5) “Look at examiner.” If no response was received from the subject, the procedure was repeated after giving strong tactile stimulation. NCSE was assessed based on Salzburg Criteria for Non-Convulsive Status Epilepticus (SCNC).[5] The EEG recordings were reviewed and interpreted by two neurologists and certified electroencephalography readers.

According to SCNC, NCSE was classified as definite NCSE and possible NCSE. Definite NCSE was assessed if: (1) epileptic discharges (EDs) >2.5 Hz were seen in “worst” 10-second epoch, or (2) EDs ≤2.5 Hz or rhythmical delta theta (RDT) activity (>0.5 Hz) with presentation of at least one of following secondary criterion: (a) subtle clinical phenomena, (2) clinical and EEG improvement to intravenous epileptic drugs, (3) typical spatiotemporal evolution of the defining grapho-elements. Possible NCSE was assessed if: (1) there was fluctuation of grapho-elements without evolution, or (2) only EEG improvement of EDs or RDT activity with intravenous epileptic drugs was presented without clinical improvement.

All patients were observed subsequently after EEG examinations until the 30th day of admission. Patient outcome was classified as 'deceased' or 'survived'. Data analysis was performed using SPSS version 20. The statistically significant association was determined if P < 0.05 with 95% confidence interval. Ethical approval was obtained from the Ethics Committee of Universitas Indonesia – Cipto Mangunkusumo General Hospital.


 » Results Top


Fifty patients with ME met the inclusion criteria and underwent the EEG examination. There were 32 (64%) patients diagnosed with NCSE based on EEG using Salzburg criteria. The demographic, clinical characteristics and outcome of all subjects can be seen in [Table 1].
Table 1: Demographic and clinical characteristics of metabolic encephalopathy subjects

Click here to view


Three common aetiologies of the ME in this study were sepsis, hyper-uremic, and hypoxia. Twenty-five patients had convulsive seizures before decreased consciousness (19 vs 6 in NCSE and non-NCSE group). Multiple aetiologies and convulsive seizures were more common in the NCSE group.

The EEG characteristics

In this study, all patients had slowing background rhythm (28 with theta wave background, 4 with delta wave background). Definite and possible NCSE diagnosis was determined by the SCNC criteria. The details of the EEG pattern were shown in [Table 2]. Only one of 12 subjects in definite NCSE had rhythmic epileptic discharge (ED) >2.5 Hz [Figure 1]. Two subjects showed ED <2.5 Hz and one of them had subtle ictal manifestation. Subtle ictal clinical manifestations were found in three subjects. All patients with possible NCSE showed only EEG improvement without clinical change during anticonvulsant administration. EEG improvement was defined as the reduction to “occasional”, i.e., 1–9% of epoch within 10 min after anticonvulsant fully applied.5 Periodic discharges and triphasic waves were seen in NCSE patients [Table 3]. Most of the NCSE patients had rhythmic delta/theta (RDT) activity.
Table 2: EEG features based on Salzburg Criteria for Non-Convulsive Status Epilepticus (n=32)

Click here to view
Figure 1: EEG features of: Male, 44 years old with sepsis encephalopathy and conscious deterioration after convulsive seizures. EEG showed repetitive epileptic discharge >2.5Hz

Click here to view
Table 3: Dominant EEG Features in NCSE Patients

Click here to view


There were only 21 patients of the NCSE (65.6%) group who were treated with antiepileptic drugs (AED) in maintenance dose until the 30th of admission. The rest of them were withdrawn from AED treatment due to some conditions (i.e., gastrointestinal bleeding) or side-effects (i.e., thrombocytopenia, anaemia). In Indonesia, the available intravenous AEDs are very limited (i.e., phenytoin, phenobarbital, diazepam, midazolam, propofol). Levetiracetam and valproic acid were administered orally through nasogastric tube.

Outcome

The mortality rate in the NCSE and non-NCSE group was 40.6% vs 44.4%. All three subjects with subtle ictal manifestation were deceased, with one subject had ED <2.5 Hz and triphasic waves [Figure 2]. Most patients with triphasic waves were deceased and patients with periodic discharge were survived [Table 3]. One patient with the attenuated background was deceased.
Figure 2: EEG features of: Female, 64 years old with decreased consciousness due to hyponatremia. EEG showed epileptic discharge (ED) <2.5Hz with subtle clinical ictal phenomenon (twitching at left corner of the lips) NCSE = Nonconvulsive Status Epilepticus; IV AED = Intra Venous Anti-epileptic Drug

Click here to view


Among the NCSE group, subjects who had single etiology were more likely to be survived compared to those with multiple aetiologies [Table 4]. Twenty-one NCSE patients received AED until day-30 and 13 of them (62%) were survived until the 30th day of admission.
Table 4: Factors associated with outcome in NCSE group

Click here to view



 » Discussion Top


Using the Salzburg Criteria for Nonconvulsive Status Epilepticus, the incidence of NCSE in ME in our study was 64%. About 60% of those patients had convulsive seizures before the NCSE diagnosis. Patients with ME who presented with convulsive seizures and had a decreased consciousness afterward should be suspected of experiencing NCSE. Differential diagnosis between ongoing ictal NCSE and postictal confusion was quite difficult to be made, especially in comatose ME patients who did not have a clear distinction between the non-convulsive ictal and postictal states.[18] EEG monitoring played a significant role to determine the ongoing ictal activity in comatose patients.

All subjects who underwent EEG examination in this study were ME patients who remain unconscious despite resolved metabolic impairments. EEG patterns in ME were commonly found in form of triphasic waves (TWs), periodic discharges, and rhythmic delta activities (RDT). As shown in this study, TWs and RDT were commonly found and improved as anticonvulsant being administered. The next question would be whether the improved TWs with anticonvulsants met the diagnostic criteria of NCSE. A retrospective study reviewing 87 EEGs had found that TWs in encephalopathy were not improved with AED and yet, increased with stimulation whereas atypical TWs due to NCSE were improved and not altered by stimulation.[19] Some authors considered NCSE in any patients with altered consciousness or confusional state with presenting atypical TWs. Atypical TWs were defined as “localized or lateralized sharp waves with triphasic configuration” and considered to be epileptogenic if they disappeared following AED treatment. Therefore, new terminology of TWs as “continuous 2/s GPDs with triphasic morphology” was used, especially in critical illness patients.[6]

In this study, all of the subjects had slowing background rhythms. During metabolic abnormalities, there would be disturbances in the ascending reticular system and the afferent input to the thalamus of which is closely related to the alpha wave originating from the reticular nuclei of the thalamus. This problem is suggested to be the cause of background rhythm slowing as seen frequently in ME.[20] Background slowing was widely present in various metabolic and endocrine abnormalities that presented with poor reactivity to photic, voice, and pain stimulation.[21]

Despite previous studies about NCSE in altered mental state and consciousness patients, the study of NCSE which focuses on ME has not been available yet. Incidence of NCSE among altered conscious patients was widely varied between 8-37%.[11],[22] However, those studies did not refer to any specific etiology. These widely varied numbers were considered due to many EEG criteria used to identify NCSE.

The diagnosis of NCSE was often delayed because of its unrecognized subtle clinical sign. Symptoms of suspected NCSE could be identified by fluctuating mental status and subtle clinical signs such as lip-smacking, and nystagmoid eyes. NCSE was often initially misdiagnosed as a psychiatric disorder in patients presenting with altered mental status.[23] NCSE could develop as de novo NCSE or occurring after a convulsive status epilepticus.[24] In this study, about 40% of patients that were diagnosed with NCSE have not had any episodes of convulsive seizure before NCSE. Twenty-one out of 32 subjects in the NCSE group had GCS >8. Therefore, we had an important consideration that GCS might not be a reliable predictor for NCSE and EEG was critically important to establish a diagnosis of NCSE.

Various metabolic abnormalities often result in the disturbed function of the sodium-potassium channel in neurons which leads to the formation of epileptic discharge. This might be presented as convulsive or non-convulsive seizures in which both could be developed into status epilepticus. In this study, more than 50% of our patients with ME experienced convulsive seizures before unconsciousness. This number was considered similar to previous studies that reported about 30-40% of patients with convulsive seizures developed into NCSE with various aetiologies.[25],[26] This type of NCSE was suggested to increase the mortality and morbidity despite the etiology, although this result was still debated.[27],[28] Distinguishing ongoing NCSE from the clinical postictal state can be difficult in some cases. Prolonged confusion is common following tonic-clonic seizures. This symptom along with ictal discharges in EEG recording was considered as NCSE. In comatose patients, a clear distinction between the ictal and postictal states is difficult and impossible to differ without EEG examination. Subtle motor activities are the clinical indicators of ongoing ictal activity, which have to be promptly managed with antiepileptic agents.

In this study, we found 3 subjects presented with subtle ictal manifestation which had a repetitive epileptiform discharge <2.5 Hz in EEG examination in 1 patient and RDT >0.5 Hz in 2 patients. All subjects with subtle ictal manifestation were deceased. Subtle ictal manifestations were often overlooked. This symptom indicated an ongoing electrical ictal activity and may lead to refractory NCSE. At the cerebral tissue level, this symptom demonstrated a maladaptive and ongoing hyper-excitable process leading to neuronal injury.[29],[30]

Several ME case reports presenting NCSE had been reported in hepatic, uremic, sepsis and hypoxic encephalopathy.[12],[25],[31] A retrospective study of septic patients in the medical intensive care unit undergoing EEG monitoring found the electrographic seizures in 16% and periodic epileptiform discharges in another 16% patients.[11] In our study, almost 70% of the NCSE group were suffered from multiple aetiologies with sepsis as the most common cause.

The mortality rate of NCSE and the non-NCSE group was similar in our study. Despite EEG improvement, the clinical improvement could not be achieved in NCSE subjects after AED administration. It explained that treating the underlying etiology was also important to decrease the mortality rate. Aggressive anti-epileptic treatment should be carefully considered since AED may contribute to morbidity and mortality of critically ill patients. Encephalopathy in sepsis patients is associated with a higher mortality rate, a higher rate of electrographic seizures and poorer outcome.[15] Continuous EEG (cEEG) was associated with increased initial seizures detection and modification of AED but was not related to improved outcome.[32] Level of consciousness could not predict the mortality among NCSE subjects in our study, differed with ME patients in another study.[33]

Neither cEEG nor repetitive EEG was performed to detect ongoing electrographic seizures in this study due to our source limitation. Therefore, follow-up and treatment evaluation were only based on clinical assessment and not by the detection of electrographic seizures.


 » Conclusion Top


Incidence of NCSE among patients with ME at our hospital was high. Despite the anti-epileptic treatment of the NCSE group, the underlying cause of ME was still the main factor that influences the outcome. Therefore, aggressive treatment of AED should be very carefully considered knowing the possible side-effect that might worsen the outcome of patients with ME.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Acknowledgements

All named authors have met the International Committee of Medical Journal Editors (ICMJE) criteria for authorship, took responsibility for the integrity of the work as a whole and have given their approval for this version to be published.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes? Epilepsia 2007;48:35-8.  Back to cited text no. 1
    
2.
Narayanan JT, Murthy JM. Nonconvulsive status epilepticus in a neurological intensive care unit: Profile in a developing country. Epilepsia 2007;48:900-6.  Back to cited text no. 2
    
3.
Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: Synopsis and comprehensive survey. Epilepsia 2012;53:1-51.  Back to cited text no. 3
    
4.
Sutter R, Kaplan PW. The neurophysiologic types of nonconvulsive status epilepticus. EEG patterns of different phenotypes. Epilepsia 2013;54:23-7.  Back to cited text no. 4
    
5.
Leitinger M, Trinka E, Gardella E, Rohracher A, Kalss G, Qerama E, et al. Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: A retrospective study. Lancet Neurol 2016;15:1054-62.  Back to cited text no. 5
    
6.
Trinka E, Leitinger M. Which EEG patterns in coma are nonconvulsive status epilepticus? Epilepsy Behav 2015;49:203-22.  Back to cited text no. 6
    
7.
Young BG, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring an investigation of variables associated with mortality. Neurology 1996;47:83-9.  Back to cited text no. 7
    
8.
Shneker BF, Fountain NB. Assessment of acute morbidity and mortality in nonconvulsive status epilepticus. Neurology 2003;61:1066-73.  Back to cited text no. 8
    
9.
Kang BS, Jhang Y, Kim YS, Moon J, Shin JW, Moon HJ, et al. Etiology and prognosis of non-convulsive status epilepticus. J Clin Neurosci 2014;21:1915-19.  Back to cited text no. 9
    
10.
Power KN, Gramstad A, Gilhus NE, Engelsen BA. Adult nonconvulsive status epilepticus in a clinical setting. Semiology, etiology, treatment and outcome. Seizure 2015;24:102-6.  Back to cited text no. 10
    
11.
Oddo M, Carrera E, Claassen J, Mayer S, Hirsch LJ. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009;37:2051-6.  Back to cited text no. 11
    
12.
Yamaguchi H, Tanaka T, Maruyama A, Nagase H. Septic encephalopathy characterized by acute encephalopathy with biphasic seizures and late reduced diffusion and early nonconvulsive status epilepticus. Case Reports Neurol Med 2016;2016:7528238. doi: 10.1155/2016/7528238.  Back to cited text no. 12
    
13.
Eleftheriadis N, Fourla E, Eleftheriadis D, Karlovasitou A. Status epilepticus as a manifestation of hepatic encephalopathy. Acta Neurol Scand 2003;107:142-4.  Back to cited text no. 13
    
14.
Algín DI, Uncu G, Adapínar DO, Erdinç OO. Nonconvulsive status epilepticus and coma. In: Dogan KH, editor. Disorder of Consciousness. London: Intechopen; 2020 [cited 2020 Jun 29]. Available from: http://dx.doi.org/10.5772/intechopen0.89428.  Back to cited text no. 14
    
15.
Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med 2014; Article ID 762320. doi: 10.1155/2014/762320.  Back to cited text no. 15
    
16.
Beghi E, Carpio A, Forsgren L, Hesdorffer D, Malmgren K, Sander J, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010;51:671-5.  Back to cited text no. 16
    
17.
Heinz UE, Rollnik JD. Outcome and prognosis of hypoxic brain damage patients undergoing neurological early rehabilitation. BMC Res Notes 2015;8:243-53.  Back to cited text no. 17
    
18.
Shorvon S, Trinka E. Nonconvulsive status epilepticus and the postictal state. Epilepsy Behav 2010;19:172-5.  Back to cited text no. 18
    
19.
Boulanger JM, Deacon C, Lécuyer D, Gosselin S, Reiher J. Triphasic waves versus nonconvulsive status epilepticus: EEG distinction. Can J Neurol Sci 2006;33:175-80.  Back to cited text no. 19
    
20.
Partanen J, Soininen H, Helkala EL, Kononen M, Kilpelainen R, Riekkinen P. Relationship between EEG reactivity and neuropsychological tests in vascular dementia. J Neural Transm 1997;104:905-12.  Back to cited text no. 20
    
21.
Faigle L, Sutter R, Kaplan PW. The electroencephalography of encephalopathy in patients with endocrine and metabolic disorders. J Clin Neurophysiol 2013;30. doi: 10.1097/WNP. 0b013e3182a73db9.  Back to cited text no. 21
    
22.
Towne AR, Waterhouse EJ, Boggs JG, Garnett LK, Brown AJ, Smith JR, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54:340-5.  Back to cited text no. 22
    
23.
Chang AK, Shinnar S. Nonconvulsive status epilepticus. Emerg Med Clin North Am 2011;29:65–72.  Back to cited text no. 23
    
24.
LaRoche SM. Seizures and encephalopathy. Semin Neurol 2011;31:194–201.  Back to cited text no. 24
    
25.
Zehtabchi S, Abdel Baki SG, Omurtag A, Sinert R, Chari G, Malhotra S, et al. Prevalence of non-convulsive seizure and other electroencephalographic abnormalities in ED patients with altered mental status. Am J Emerg Med 2013;31:1578–82.  Back to cited text no. 25
    
26.
Yuan F, Yang F, Li W, Yang X, Gao Q, Bi L, et al. Nonconvulsive status epilepticus after convulsive status epilepticus. Clinical features, outcomes, and prognostic factors. Epilepsy Res 2018;142:53-7.  Back to cited text no. 26
    
27.
Holtkamp M, Meierkord H. Nonconvulsive status epilepticus. A diagnostic and therapeutic challenge in the intensive care setting. Ther Adv Neurol Disord 2011;4:169–81.  Back to cited text no. 27
    
28.
DeLorenzo RJ, Waterhouse EJ, Towne ER, Boggs JG, Ko D, DeLorenzo GA. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-40.  Back to cited text no. 28
    
29.
Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults. Clinical forms and treatment. Lancet Neurol 2007;6:329-39.  Back to cited text no. 29
    
30.
Chen JW, Wasterlain CG. Status epilepticus. Pathophysiology and management in adults. Lancet Neurol 2006;5:246-56.  Back to cited text no. 30
    
31.
Jhun P, Kim H. Nonconvulsive status epilepticus in hepatic encephalopathy. West J Emerg Med 2011;12:372–4.  Back to cited text no. 31
    
32.
Rossetti AO, Schindler K, Sutter R, Rüegg S, Zubler F, Novy J, et al. Continuous vs routine electroencephalogram in critically ill adults with altered consciousness and no recent seizure: A multicenter randomized clinical trial. JAMA Neurol 2020;77:1225-32.  Back to cited text no. 32
    
33.
Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, aetiologies, and mortalities. JAMA Neurol 1996;275:470-3.  Back to cited text no. 33
    


    Figures

  [Figure 1], [Figure 2]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow